Matches in Library of Congress for { <http://lccn.loc.gov/2004013542> ?p ?o. }
Showing items 1 to 29 of
29
with 100 items per page.
- 2004013542 contributor B9821141.
- 2004013542 created "c2005.".
- 2004013542 date "2005".
- 2004013542 date "c2005.".
- 2004013542 dateCopyrighted "c2005.".
- 2004013542 description "Includes bibliographical references and index.".
- 2004013542 description "Mechanism of action of topoisomerase I poisons / Leroy F. Liu and Shyamal D. Desai -- Crystallographic insight into the mechanism of drug-induced topoisomerase I DNA damage / Alex B. Burgin, Jr., Bart L. Staker, and Lance Stewart -- Inhibitors of topoisomerase I function / Sidney M. Hecht -- Cytotoxic mechanisms of the topoisomerase I inhibitors / Yves Pommier ... [et al.] -- Biochemical and genetic analyses of DNA topoisomerase I-mediated DNA damage / Robert C.A.M. Van Waardenburg and Mary-Ann Bjornsti -- Preclinical models for evaluating topoisomerase-I targeted drugs / Aarti S. Juvekar ... [et al.] -- Mechanisms of resistance to camptothecins / Zeshaan A. Rasheed and Eric H. Rubin -- Recent advances in camptothecin drug design and delivery strategies / Thomas G. Burke ... [et al.] -- Clinical experience with 9-aminocamptothecin: lessons for new drug development / Chris H. Takimoto -- Clinical studies of rubitecan (9-nitro 20(s) camptothecin) / Hilary Hewes, Judith A. Smith, and Claire Verschraegen -- Irinotecan: current clinical status and pharmacological aspects / Laurent P. Rivory -- Clinical experience with topotecan / Aimee K. Bence and Val R. Adams -- The clinical development of lurtotecan: experience with water-soluble and liposomal forms / Keith T. Flaherty ... [et al.] -- Preclinical and clinical development of dx-8951f (exatecan mesylate): a hexacyclic camptothecin analog / Eric K. Rowinsky -- Camptothecins in the treatment of primary brain tumors / Clinton F. Stewart, Markos Leggas, and Henry S. Friedman -- Camptothecins in the treatment of lung cancer / Pankaj Kumar ... [et al.] -- Use of camptothecins in the treatment of leukemia and related disorders / Bejamin M.F. Mow and Scott H. Kaufmann.".
- 2004013542 extent "xiii, 460 p. :".
- 2004013542 identifier "1588290271 (hardcover : alk. paper)".
- 2004013542 identifier 2004013542-d.html.
- 2004013542 identifier 2004013542.html.
- 2004013542 isPartOf "Cancer drug discovery and development".
- 2004013542 issued "2005".
- 2004013542 issued "c2005.".
- 2004013542 language "eng".
- 2004013542 publisher "Totowa, N.J. : Humana Press,".
- 2004013542 subject "616.99/4061 22".
- 2004013542 subject "Antineoplastic Agents, Phytogenic therapeutic use.".
- 2004013542 subject "Camptothecin analogs & derivatives.".
- 2004013542 subject "Camptothecin pharmacology.".
- 2004013542 subject "Camptothecin therapeutic use.".
- 2004013542 subject "Camptothecin.".
- 2004013542 subject "Cancer Chemotherapy.".
- 2004013542 subject "Neoplasms drug therapy.".
- 2004013542 subject "QV 269 C1989 2005".
- 2004013542 subject "RC271.C35 C345 2005".
- 2004013542 tableOfContents "Mechanism of action of topoisomerase I poisons / Leroy F. Liu and Shyamal D. Desai -- Crystallographic insight into the mechanism of drug-induced topoisomerase I DNA damage / Alex B. Burgin, Jr., Bart L. Staker, and Lance Stewart -- Inhibitors of topoisomerase I function / Sidney M. Hecht -- Cytotoxic mechanisms of the topoisomerase I inhibitors / Yves Pommier ... [et al.] -- Biochemical and genetic analyses of DNA topoisomerase I-mediated DNA damage / Robert C.A.M. Van Waardenburg and Mary-Ann Bjornsti -- Preclinical models for evaluating topoisomerase-I targeted drugs / Aarti S. Juvekar ... [et al.] -- Mechanisms of resistance to camptothecins / Zeshaan A. Rasheed and Eric H. Rubin -- Recent advances in camptothecin drug design and delivery strategies / Thomas G. Burke ... [et al.] -- Clinical experience with 9-aminocamptothecin: lessons for new drug development / Chris H. Takimoto -- Clinical studies of rubitecan (9-nitro 20(s) camptothecin) / Hilary Hewes, Judith A. Smith, and Claire Verschraegen -- Irinotecan: current clinical status and pharmacological aspects / Laurent P. Rivory -- Clinical experience with topotecan / Aimee K. Bence and Val R. Adams -- The clinical development of lurtotecan: experience with water-soluble and liposomal forms / Keith T. Flaherty ... [et al.] -- Preclinical and clinical development of dx-8951f (exatecan mesylate): a hexacyclic camptothecin analog / Eric K. Rowinsky -- Camptothecins in the treatment of primary brain tumors / Clinton F. Stewart, Markos Leggas, and Henry S. Friedman -- Camptothecins in the treatment of lung cancer / Pankaj Kumar ... [et al.] -- Use of camptothecins in the treatment of leukemia and related disorders / Bejamin M.F. Mow and Scott H. Kaufmann.".
- 2004013542 title "Camptothecins in cancer therapy / edited by Val R. Adams and Thomas G. Burke.".
- 2004013542 type "text".